events
Mark your calendar for November 19-21 and meet us at Fi Europe 2024, Messe Frankfurt, Germany. We look forward to connecting with you at this exciting event!
Learn More >>
Products

Enzymes for Research, Diagnostic and Industrial Use

Products
Online Inquiry

Our Products Cannot Be Used As Medicines Directly For Personal Use.

24 hour
Promise

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.

PD173955

Cat No.
CEI-1099
Description
PD173955 is an ATP-competitive, dual Src/Abl kinase inhibitor. It is a potent inhibitor of Bcr-Abl with an IC50 of 1-2 nM in kinase inhibition assays. In cellular growth assays it inhibits Bcr-Abl-dependent substrate tyrosine phosphorylation. PD173955 al
Abbr
PD173955(BCR, ABL1, SRC)
Alias
ALL, BCR1, CML, D22S11, D22S662, PHL
Product Overview
ATP-competitive, dual Src/Abl kinase inhibitor
CAS No.
260415-63-2
Molecular Weight
443.35
Purity
> 95%
Stability
2 years -20 centigrade Powder
1 month -4 centigrade in DMSO
More than one month -80 centigrade in DMSO
Storage
4 centigrade
Synonyms
ALL, BCR1, CML, D22S11, D22S662, PHL
Targets
Bcr-Abl, c-Src
IC50
2-35
Molecular Formula
C21H16Cl2N4OS
Chemical Name
6-(2,6-dichlorophenyl)-8-methyl-2-(3-(methylthio)phenylamino)pyrido[2,3-d]pyrimidin-7(8H)-one
Solubility
DMSO > 112mg/mL Water >1mg/mL Ethanol > 4mg/mL

Our Products Cannot Be Used As Medicines Directly For Personal Use.

0
Click unfold / close
Inquiry Basket
Delete selected Quote Check Out
Decide to move out of the shopping cart?
Sure No, Back

Please choose product!

< Go Back
You have already added to buy this product